Merck Denies Withholding Vaccines

2 October 1994

Merck & Co has denied an accusation by US Health and Human Services Secretary Donna Shalala that it is withholding its vaccines from the Vaccine for Children program.

The Associated Press reported that Ms Shalala rebuked the company as the sole holdout on contracts to sell vaccines to the government at special prices for needy children.

Merck is the only supplier of the measles, mumps and rubella vaccines and a high-risk Hemophilus influenzae vaccine; the other manufacturers involved in the program have already signed their contracts. SmithKline Beecham said the contracts were just about the same as those the companies have been signing in the past to supply vaccine to public clinics.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight